Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke

Stroke

Volumn 42, Issue 5, 2011, Pages 1307-1313

  Ford, Andria L ^a   An, Hongyu ^c   D'Angelo, Gina ^a   Ponisio, Rosana ^b   Bushard, Patrick ^a   Vo, Katie D ^b   Powers, William J ^c   Lin, Weili ^c   Lee, Jin Moo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ischemic stroke; reperfusion; statin

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG USE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REPERFUSION; RETROSPECTIVE STUDIES; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955479915     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.600957     Document Type: Article

References (45)

1. Amarenco P, Bogousslavsky J, Callahan A III, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549-559. (Pubitemid 44202151)
2. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, et al. Statin treatment and stroke outcome in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke. 2009; 40:3526-3531.
3. Greisenegger S, Müllner M, Tentschert S, Lang W, Lalouschek W. Effect of pretreatment with statins on the severity of acute ischemic cerebro-vascular events. J Neurol Sci. 2004;221:5-10. (Pubitemid 38721284)
4. Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke. 2004;35:1117-1121.
5. Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A, Paul Coverdell National Acute Stroke Registry Michigan Prototype Investi-gators. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke. 2008;39:1779-1785.
6. Yoon SS, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J, Davis L, Baird AE. Rising statin use and effect on ischemic stroke outcome. BMC Med. 2004;2:4.
7. Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, Dávalos A, Castillo J. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007;69:904-910. (Pubitemid 47329591)
8. Bourcier T, Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:556-562. (Pubitemid 30086117)
9. Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T, Qiu J, Amin-Hanjani S, Huang PL, Liao JK, Lo EH, Moskowitz MA. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:722-729. (Pubitemid 40705607)
10. Laufs U, Gertz K, Huang P, Nickenig G, Böhm M, Dirnagl U, Endres M. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke. 2000;31:2442-2449.
11. Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Mos-kowitz MA. Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke. 2001;32:980-986.
12. Nagaraja TN, Knight RA, Croxen RL, Konda KP, Fenstermacher JD. Acute neurovascular unit protection by simvastatin in transient cerebral ischemia. Neurol Res. 2006;28:826-830. (Pubitemid 44904456)
13. Filusch A, Buss S, Hardt S, Katus HA, Kuecherer HF, Hansen A. Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography. Echocardiography. 2008;25: 974-981.
14. Yamada M, Huang Z, Dalkara T, Endres M, Laufs U, Waeber C, Huang PL, Liao JK, Moskowitz MA. Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment. J Cereb Blood Flow Metab. 2000;20:709-717. (Pubitemid 30217509)
15. Derdeyn CP, Carpenter DA, Videen TO, Grubb RL Jr, Powers WJ. No effect of low-dose statins treatment on cerebral blood flow in humans with atherosclerotic cerebrovascular disease. J Cereb Blood Flow Metab. 2007;27:1643-1648. (Pubitemid 47301450)
16. Georgiadis AL, Hussein HM, Vazquez G, Shah Q, Suri MF, Ezzeddine MA, Qureshi AI. Premorbid use of statins is associated with higher recanalization rates in patients with acute ischemic stroke undergoing endovascular treatment. J Neuroimaging. 2009;19:19-22.
17. Sillberg VA, Wells GA, Perry JJ. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hem-orrhage: a meta-analysis. Stroke. 2008;39:2622-2626.
18. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical anal-ysis. Magn Reson Med. 1996;36:715-725. (Pubitemid 26376710)
19. Kuppusamy K, Lin W, Cizek GR, Haacke EM. In vivo regional cerebral blood volume: Quantitative assessment with 3D T1-weighted pre-and postcontrast MR imaging. Radiology. 1996;201:106-112. (Pubitemid 26314373)
20. Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med. 1996;36:726-736. (Pubitemid 26376711)
21. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal. 2001;5:143-156. (Pubitemid 35282800)
22. Parsons MW, Yang Q, Barber PA, Darby DG, Desmond PM, Gerraty RP, Tress BM, Davis SM. Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct. Stroke. 2001;32:1581-1587. (Pubitemid 32631909)
23. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211. (Pubitemid 32947377)
24. Endres M. Statins and stroke. J Cereb Blood Flow Metab. 2005;25: 1093-1110. (Pubitemid 41710736)
25. Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, Böhm M, Schoen FJ, Moskowitz MA, Liao JK. Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest. 2000;106: 15-24. (Pubitemid 30437236)
26. Shabanzadeh AP, Shuaib A, Wang CX. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res. 2005;1042:1-5.
27. Murakami M, Fujioka S, Hirata Y, Kuratsu J. Low-dose of statin treatment improves cerebrovascular reactivity in patients with ischemic stroke: single photon emission computed tomography analysis. J Stroke Cerebrovasc Dis. 2008;17:16-22.
28. Albert MA, Danielson E, Rifai N, Ridker PM, PRINCE Investigators. Effect of statin therapy on c-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA. 2001;286:64-70. (Pubitemid 32606333)
29. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Macfadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Trial Study Group. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the JUPITER trial. Lancet. 2009;373:1175-1182.
30. Pahan K, Sheikh FG, Namboodiri AM, Singh I. Lovastatin and phenyl-acetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest. 1997;100: 2671-2679. (Pubitemid 28007534)
31. Marino F, Guasti L, Cosentino M, Rasini E, Ferrari M, Maio RC, Loraschi A, Cimpanelli MG, Schembri L, Legnaro M, Molteni E, Crespi C, Crema F, Venco A, Lecchini S. Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and T lymphocytes. J Hypertens. 2008;26:1147-1155 (Pubitemid 351670506)
32. An HF, Vo K, Eldeniz C, Ponisio R, Zhu H, Li Y, Chen Y, Powers WJ, Lee JM, Lin W. Early changes of tissue perfusion after tpa in hyperacute ischemic stroke. Stroke. 2011;42:65-72.
33. Bang OY, Kim GM, Chung CS, Kim SJ, Kim KH, Jeon P, Saver JL, Liebeskind DS, Lee KH. Differential pathophysiological mechanisms of stroke evolution between new lesions and lesion growth: Perfusion-weighted imaging study. Cerebrovasc Dis. 29:328-335.
34. Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management. Postgrad Med J. 2008;84:412-417.
35. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33:1315-1320. (Pubitemid 34517053)
36. Janjua N, Alkawi A, Suri MF, Qureshi AI. Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol. 2008;29:253-258. (Pubitemid 351287876)
37. Ali LK, Saver JL. The ischemic stroke patient who worsens: new assessment and management approaches. Rev Neurol Dis. 2007;4:85-91. (Pubitemid 47016203)
38. Liebeskind DS. Collaterals in acute stroke: beyond the clot. Neuro-imaging Clin North Am. 2005;15:553-573. (Pubitemid 41796939)
39. Soares BP, Tong E, Hom J, Cheng SC, Bredno J, Boussel L, Smith WS, Wintermark M. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: A proof of concept using ct in acute ischemic stroke patients. Stroke. 41:e34-e40.
40. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Anderson CS. Long-term disability after first-ever stroke and related prognostic factors in the Perth Community Stroke Study, 1989-1990. Stroke. 2002;33: 1034-1040. (Pubitemid 34293588)
41. Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke. 2002;33:1041-1047. (Pubitemid 34293589)
42. Johnson-Anuna LN, Eckert GP, Franke C, Igbavboa U, Müller WE, Wood WG. Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem. 2007;101:77-86. (Pubitemid 46426484)
43. Butterick TA, Igbavboa U, Eckert GP, Sun GY, Weisman GA, Müller WE, Wood WG. Simvastatin stimulates production of the antiapoptotic protein Bcl-2 via endothelin-1 and NFATc3 in SH-SY5Y cells. Mol Neurobiol. 2010;41:384-391.
44. Bösel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, Megow D, Dirnagl U, Hörtnagl H, Fink KB, Endres M. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem. 2005;92:1386-1398. (Pubitemid 40389208)
45. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53: 743-751 (Pubitemid 36622511)